Clinical Trial Update: A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced, Unresectable Recurrent, or Metastatic Esophageal Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating atezolizumab plus tiragolumab with paclitaxel and cisplatin as first-line therapy in unresectable or metastatic esophageal cancer compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)
• Tiragolumab (tiragolumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Esophageal Cancer | Phase 3 | Status: COMPLETED | Results posted: 2026-04-09